Mukadi-Kaningu Pierre, Muele Fortunat Kandanda, Tshimanga Nestor, Unandu Joel, Mbamba Brigitte Mbuyam-Ba, Sompwe Eric Mukomena
Université Pédagogique Nationale, B.P. 8815, Kinshasa 1, DR Congo.
Institut National de Recherche Biomédicale, Kinshasa, DR Congo.
Malariaworld J. 2024 Feb 9;15:2. doi: 10.5281/zenodo.10630995. eCollection 2024.
In the current study we assessed clinical laboratories' staff ability across the city of Kinshasa with particular focus on their practices and performance regarding malaria microscopy.
This was a non-random cross-sectional study included clinical laboratories in Kinshasa and focused on cross-checking of blood slides, a questionnaire and checklist according to standardised analytic malaria microscopy procedures. Regarding the cross-checking of slides, participant responses were considered 'corrects' in cases of complete congruence with the reference; 'acceptable' for malaria-positive slides but no identification of species, stage of development, parasite density and/or reported as instead of 'P. non falciparum'; and 'incorrect' if 'false positive' and 'false negative' cases.
Eighty-eight among the 90 targeted clinical laboratories (participation 97.8%) took part in the investigation from February to July 2019. The ability assessment revealed that individuals qualified to perform thick blood films (TBF) according to the national malaria control program (NMCP) procedures ranged from 48.6% to 100.0%. Overall cross-checking performance of 167 eligible routine slides was relatively low: 37.7%; 25.8% and 36.5% of correct, acceptable and incorrect responses, respectively. The first routine slide was correctly and acceptably scored respectively by 35.3% and 28.2% of participating laboratories (n = 85); and the second, by 40.2% and 23.2% respectively (n = 82). The sensitivity and specificity were found to be 79.4% and 53.8%, respectively. However, the relative high scores reported in relation with the ability needed to perform TBF based on NMCP standards contrasted with the poor performance from cross-checking slides. Consecutively, only one-third of the 88 participating laboratories reached a score > 60% in agreement with NMCP procedures and had acceptable responses to cross-checked slides.
The study was conducted as part of the activities relating to "Ensuring early diagnosis and prompt malaria treatment" component of the national malaria control strategy with NMCP support. More laboratories must implement clear and standardised malaria microscopy procedures, and need to include more rigorous quality control.
在本研究中,我们评估了金沙萨市临床实验室工作人员的能力,特别关注他们在疟疾显微镜检查方面的操作和表现。
这是一项非随机横断面研究,涵盖了金沙萨的临床实验室,重点是根据标准化的疟疾显微镜分析程序对血涂片、问卷和清单进行交叉核对。关于血涂片的交叉核对,若参与者的回答与参考结果完全一致,则视为“正确”;对于疟疾阳性血涂片,但未鉴定出物种、发育阶段、寄生虫密度和/或报告为“非恶性疟原虫”而非“间日疟原虫”,则视为“可接受”;若出现“假阳性”和“假阴性”情况,则视为“错误”。
在90家目标临床实验室中,有88家(参与率97.8%)于2019年2月至7月参与了调查。能力评估显示,根据国家疟疾控制计划(NMCP)程序有资格进行厚血膜(TBF)检查的人员比例在48.6%至100.0%之间。对167份合格常规血涂片的总体交叉核对表现相对较低:正确、可接受和错误回答分别占37.7%、25.8%和36.5%。参与实验室(n = 85)中,35.3%和28.2%的实验室对第一张常规血涂片的评分正确且可接受;对于第二张血涂片,这两个比例分别为40.2%和23.2%(n = 82)。灵敏度和特异性分别为79.4%和53.8%。然而,与基于NMCP标准进行TBF检查所需能力相关的较高分数与交叉核对血涂片的较差表现形成了对比。连续地,88家参与实验室中只有三分之一的实验室在符合NMCP程序方面得分> 60%,并且对交叉核对血涂片的回答可接受。
本研究是在国家疟疾控制战略“确保早期诊断和及时治疗疟疾”部分的活动中,在NMCP的支持下开展的。更多实验室必须实施清晰且标准化的疟疾显微镜检查程序,并需要纳入更严格的质量控制。